Lake Point Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
EP
Lake Point Wealth Management's ARKG Position: Q4 2021 in Review
Lake Point Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2021, closing a stake of 10 shares — an estimated $1K sold.
Lake Point Wealth Management first reported a position in ARKG in Q2 2021 and held it in 2 quarters. The position peaked at $1K in Q3 2021. 460 funds tracked by Wall St. Rank hold ARKG as of Q4 2021.
- Lake Point Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q4 2021 after selling out during the quarter.
- Lake Point Wealth Management sold 10 ARK Genomic Revolution ETF shares in Q4 2021, an estimated $1K.
- Lake Point Wealth Management first reported a position in ARK Genomic Revolution ETF in Q2 2021 and held it in 2 quarters.
- Lake Point Wealth Management's ARK Genomic Revolution ETF position peaked at $1K in Q3 2021.
- 460 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2021.
Based on Lake Point Wealth Management's 13F filing for Q4 2021, filed 23 Feb 2022.